Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Virol J. 2012 Jan 24;9:30. doi: 10.1186/1743-422X-9-30.
Although primary and established human hepatoma cell lines have been evaluated for hepatitis C virus (HCV) infection in vitro, thus far only Huh7 cells have been found to be highly permissive for infectious HCV. Since our understanding of the HCV lifecycle would benefit from the identification of additional permissive cell lines, we assembled a panel of hepatic and non-hepatic cell lines and assessed their ability to support HCV infection. Here we show infection of the human hepatoma cell lines PLC/PRF/5 and Hep3B with cell culture-derived HCV (HCVcc), albeit to lower levels than that achieved in Huh7 cells. To better understand the reduced permissiveness of PLC and Hep3B cells for HCVcc infection, we performed studies to evaluate the ability of each cell line to support specific steps of the viral lifecycle (i.e. entry, replication, egress and spread).
We found that while the early events in HCV infection (i.e. entry plus replication initiation) are cumulatively equivalent or only marginally reduced in PLC and Hep3B cells, later steps of the viral life cycle such as steady-state replication, de novo virus production and/or spread are impaired to different degrees in PLC and Hep3B cultures compared to Huh7 cell cultures. Interestingly, we also observed that interferon stimulated gene (i.e. ISG56) expression was significantly and differentially up-regulated in PLC and Hep3B cells following viral infection.
We conclude that the restrictions observed later during HCV infection in these cell lines could in part be attributed to HCV-induced innate signaling. Nevertheless, the identification of two new cell lines capable of supporting authentic HCVcc infection, even at reduced levels, expands the current repertoire of cell lines amendable for the study of HCV in vitro and should aid in further elucidating HCV biology and the cellular determinants that modulate HCV infection.
虽然已对原代和已建立的人肝癌细胞系进行了体外丙型肝炎病毒(HCV)感染评估,但迄今为止,只有 Huh7 细胞被发现对感染性 HCV 高度允许。由于我们对 HCV 生命周期的理解将受益于其他允许的细胞系的鉴定,我们组装了一组肝和非肝细胞系,并评估了它们支持 HCV 感染的能力。在这里,我们显示人肝癌细胞系 PLC/PRF/5 和 Hep3B 可感染细胞培养衍生的 HCV(HCVcc),尽管感染水平低于 Huh7 细胞。为了更好地理解 PLC 和 Hep3B 细胞对 HCVcc 感染的允许性降低,我们进行了研究以评估每种细胞系支持病毒生命周期特定步骤(即进入、复制、出芽和传播)的能力。
我们发现,虽然 HCV 感染的早期事件(即进入加复制起始)在 PLC 和 Hep3B 细胞中累积相等或仅略有降低,但病毒生命周期的后期步骤,如稳态复制、从头病毒产生和/或传播,在 PLC 和 Hep3B 培养物中与 Huh7 细胞培养物相比受到不同程度的损害。有趣的是,我们还观察到,在病毒感染后,干扰素刺激基因(即 ISG56)的表达在 PLC 和 Hep3B 细胞中显著且不同地上调。
我们得出结论,在这些细胞系中 HCV 感染后期观察到的限制可能部分归因于 HCV 诱导的先天信号。然而,鉴定两种新的能够支持真实 HCVcc 感染的细胞系,即使感染水平降低,也扩展了目前适合体外 HCV 研究的细胞系组合,并有助于进一步阐明 HCV 生物学和调节 HCV 感染的细胞决定因素。